MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 2.790
+0.010 (0.36%)
Aug 3, 2026, 11:44 AM CET
MaaT Pharma Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4.52 | 4.52 | 3.22 | 2.23 | 1.43 | 0.97 |
Revenue Growth | 15.35% | 40.67% | 44.33% | 55.82% | 47.16% | 46.71% |
Gross Profit Gross Profit Growth | 3.12 | 3.12 | 1.97 | 2.23 | 1.09 | 0.97 |
Operating Income Operating Income Growth | -29.73 | -29.73 | -28.43 | -22.94 | -13.56 | -10.1 |
Net Income Net Income Growth | -31.06 | -31.06 | -28.9 | -18.92 | -13.71 | -8.24 |
Earnings Per Share EPS Growth | -1.95 | -1.95 | -2.21 | -1.70 | -1.39 | -3.70 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Export and Intra-Community Export and Intra-Community Growth | 0.07 | 0.07 | - | - | - | - |
France France Growth | 4.46 | 4.46 | 3.22 | 2.23 | 1.43 | 0.97 |
Total Total Growth | 4.52 | 4.52 | 3.22 | 2.23 | 1.43 | 0.97 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 24.96 | 24.96 | 20.22 | 24.48 | 35.55 | 43.4 |
Total Debt Total Debt Growth | 17.44 | 17.44 | 15.96 | 6.84 | 9.23 | 3.44 |
Net Cash (Debt) Net Cash Growth | 7.52 | 7.52 | 4.26 | 17.64 | 26.32 | 39.96 |
Net Cash Growth | 1032.83% | 76.45% | -75.83% | -32.99% | -34.14% | 147.21% |
Net Cash Per Share Net Cash Per Share Growth | 0.47 | 0.47 | 0.33 | 1.55 | 2.66 | 16.47 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -15.72 | -15.72 | -22.04 | -18.67 | -12.61 | -7.93 |
Capital Expenditures CapEx Growth | -0.61 | -0.61 | -0.75 | -1.09 | -0.66 | -0.24 |
Free Cash Flow Free Cash Flow Growth | -16.33 | -16.33 | -22.79 | -19.76 | -13.27 | -8.17 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.05% | 69.05% | 61.13% | 100.00% | 76.29% | 100.00% |
Operating Margin | -657.14% | -657.14% | -883.95% | -1029.70% | -948.04% | -1039.05% |
Pretax Margin | -686.58% | -686.58% | -898.76% | -1012.30% | -958.95% | -1048.87% |
Profit Margin | -686.58% | -686.58% | -898.76% | -849.25% | -958.95% | -847.57% |
FCF Margin | -360.88% | -360.88% | -708.77% | -886.92% | -927.76% | -840.46% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 11.58 | 20.01 | 34.53 | 36.39 | 55.60 | 90.51 |